[HTML][HTML] Immunological and clinical efficacy of COVID-19 vaccines in immunocompromised populations: a systematic review

S Galmiche, LBL Nguyen, E Tartour… - Clinical Microbiology …, 2022 - Elsevier
Background Available data show that COVID-19 vaccines may be less effective in
immunocompromised populations, who are at increased risk of severe COVID-19 …

Precision vaccine adjuvants for older adults: a scoping review

E Nanishi, A Angelidou, C Rotman… - Clinical Infectious …, 2022 - academic.oup.com
Older adults, defined as those≥ 60 years of age, are a growing population vulnerable to
infections including severe acute respiratory syndrome coronavirus 2. Although …

[HTML][HTML] What motivates people to receive continuous COVID-19 vaccine booster shots? An expectation confirmation theory perspective

J Liu, S Lu, C Lu - Healthcare, 2022 - mdpi.com
(1) Background: Abundant evidence has shown that the COVID-19 vaccine booster is highly
effective against the Omicron variant. It is of great practical significance to explore the factors …

[HTML][HTML] Substantial effect of phytochemical constituents against the pandemic disease influenza—a review

AB Devi, R Sarala - Future Journal of Pharmaceutical Sciences, 2021 - Springer
Background Influenza is an acute respiratory tract infection caused by the influenza virus.
Vaccination and antiviral drugs are the two methods opted to control the disease. Besides …

[HTML][HTML] Designing a conjugate vaccine targeting Klebsiella pneumoniae ST258 and ST11

M Li, M Yu, Y Yuan, D Li, D Ye, M Zhao, Z Lin, L Shi - Heliyon, 2024 - cell.com
Klebsiella pneumoniae (K. pneumoniae) is a common bacterium that can cause iatrogenic
infection. Recently, the rise of antibiotic resistance among K. pneumoniae strains is one key …

[HTML][HTML] Should we vaccinate the better seroconverters or the most vulnerable? Game changing insights for COVID-19 vaccine prioritization policies

A AbdelMassih, M El Shershaby, H Gaber… - Egyptian Pediatric …, 2021 - Springer
Background With the rapid rise in COVID 19 cases incomparable to the number of
vaccinations available, there has been a demand to prioritize the older age groups receiving …